Charles Fisher’s AI startup has attracted some significant capital as it works to speed up solutions for both pharma companies, and their patients. His venture, Unlearn, has attracted funding from top-tier investors like Mubadala Capital Ventures, Insight Partners, Radical Ventures, and DCVC Bio.

The post Charles Fisher On Raising $70 Million To Help Develop Drugs More Ethically appeared first on Alejandro Cremades.